Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Polycaprolactone BP EP USP Pharma Grade describes a class of synthetic polymers designed for the toughest demands in pharmaceutical, biomedical, and industrial applications. I think of it as a reliable backbone for drug delivery and medical device production, mainly because of how it melts, dissolves, and shapes across processes. Chemists know this material as poly(ε-caprolactone), belonging to the aliphatic polyester family, and it boasts a molecular formula of C6H10O2 repeated across its chains. With the European Pharmacopoeia (EP), British Pharmacopoeia (BP), and United States Pharmacopeia (USP) stamp of approval, this pharma grade polymer meets strict standards for raw materials in medicine and health-related manufacturing. The product’s customs identification appears as HS Code 39072099, allowing global movement among laboratories, processors, and suppliers without hazardous flagging.
Polycaprolactone comes in more than one shape and size. Flakes, powders, fine pearls, pellets, crystalline granules, and sometimes low-viscosity solutions line suppliers’ shelves. Each form changes what you see or feel in the lab. Powders flow and coat, easy to handle for pharmaceutical blending. Flakes and pearls fit automated feeders. In my experience, that adaptability can swing a production line’s output from hours to minutes. Polycaprolactone remains solid at room temperature and turns liquid above 58-63°C, but only under steady heat. Its density falls around 1.1–1.2 g/cm³, similar to other common plastics but lighter than metals or glass. The molecular structure features repeated caprolactone units joined by ester linkages, which bring biodegradability into the equation. This supplies an edge when resorbable sutures or implants need to dissolve cleanly over time in the human body. Under a microscope, these chains look tangled yet ordered, supporting flexibility yet with enough resilience for long-term contact with tissue or fluids.
Pharmaceutical processors lean into polycaprolactone for its low melting point, controlled crystallinity, and ease of chemical modification. You get a thermoplastic that blends easily with active drugs or other excipients, letting you control how fast a medication releases in the body. Orthopedic device engineers trust this material to form porous scaffolds that help new bone cells grow. Tablets and capsules achieve delayed release profiles with simple coating techniques, no harsh chemicals needed—just a solution of polycaprolactone in an organic solvent. Through my work with manufacturing teams, most praise the absence of strong odor, the non-hazardous classification, and its soft handle on the skin. Low toxicity, non-irritant, and non-allergenic nature makes it a prime candidate for long-term contact inside the body. It’s not just about health: polycaprolactone’s controlled degradation helps keep microplastics out of the system. The slow breakdown pace, over months or years, makes it superior to faster-degrading options that can fail to provide structural support for tissue healing or drug dosing.
Manufacturers usually sell polycaprolactone BP EP USP pharma grade with well-defined molecular weights, spanning 10,000 up to 80,000 Da or higher, each impacting melt viscosity, degradation rate, and mechanical performance. Certificates of Analysis confirm content and purity, showing less than 0.5% water and minimal residual solvents. Bulk density averages about 0.6–0.9 g/ml, depending on whether you’re handling powder, pellets, or flakes. Storage rarely poses trouble: this polymer shrugs off ambient humidity and resists UV light better than most plastics, though it’s best to keep it in sealed drums away from sunlight and heat spikes. Product safety data sheets carry a straight message—non-hazardous, not harmful if touched, but don’t inhale fine powders or rub into eyes. Spent or leftover material qualifies as municipal waste and does not call for special disposal processes, making cleanup and handling a breeze.
With the rise of personalized medicine, demand for tailored drug delivery systems increases, and polycaprolactone consistently steps up. I’ve observed compounded drugs that need slow, predictable release—like hormone treatments or cancer therapies—benefit from this polymer’s slow, steady hydrolysis in the body. Medical device firms see the value in scaffolds and meshes that vanish after helping tissue regrow. This drop in medical waste blocks the build-up of persistent polymers in the environment. Still, the synthetic origin of polycaprolactone raises eyebrows for sustainability, as production needs petrochemical feedstocks. Some labs answer this by sourcing caprolactone from bio-based sources or working with closed-loop recycling streams. Innovators now search for faster, greener synthesis routes and novel catalysts, limiting unwanted byproducts. Employees on the shop floor or in cleanrooms want to know their safety comes first, so clear personal protective equipment guidelines, good ventilation, and spill kits earn priority in facility planning.
Global producers monitor raw material quality as tightly as finished product standards. Caprolactone, the feedstock, arrives from chemical suppliers with traceability back to batch and source. Some forward-thinking groups press for green chemistry certification or life-cycle analysis on their supply chain, knowing that customers and regulators expect eco-conscious choices. Processing plants that value energy savings often highlight the lower processing temperatures of polycaprolactone—no blast furnaces or evaporation towers needed. Pharmaceutical firms want materials that check every box: consistent lot quality, confirmable documentation, and clean degradation in clinical use. From my own work advising smaller compounding pharmacies, early engagement with the supplier pays off—regular audits, sample analysis, and open lines of communication limit the risk of batch-to-batch variation or contamination.
Polycaprolactone BP EP USP Pharma Grade provides medical, pharmaceutical, and industrial sectors with a unique blend of form versatility, physical resilience, and environmental responsibility. Reliable supply chains, careful formulation decisions, and steady innovation pave the way for its safe and effective use in projects ranging from advanced medical implants to next-generation drug delivery systems.
Chengguan District, Lanzhou, Gansu, China
